Showing results (1541-1550 of 2,164) with videos related to
Sort By:
Pageof 217
Communications Materials|December 5, 2022
Graph neural networks for materials science and chemistryPatrick Reiser, Marlen Neubert, André Eberhard, et al.Brain Sciences|May 28, 2022
Hippocampal Cytokine Release in Experimental Epileptogenesis-A Longitudinal In Vivo Microdialysis StudyKai Siebenbrodt, Vanessa Schütz, Lara S Costard, et al.The AAPS Journal|December 20, 2022
Development and Validation of a Western Blot Method to Quantify Mini-Dystrophin in Human Skeletal Muscle BiopsiesCatherine I Soderstrom, Jennifer Larsen, Carolina Owen, et al.Frontiers in Microbiology|March 30, 2018
Revisiting Francisella tularensis subsp. holarctica, Causative Agent of Tularemia in Germany With Bioinformatics: New Insights in Genome Structure, DNA Methylation and Comparative Phylogenetic AnalysisAnne Busch, Prasad Thomas, Eric Zuchantke, et al.European Journal of Clinical Pharmacology|May 31, 2012
Epidemiology and potential associated risk factors of drug-related problems in hospitalised children in the United Kingdom and Saudi ArabiaAsia N Rashed, Antje Neubert, Stephen Tomlin, et al.Scientific Reports|January 11, 2026
Cannabidiol reduces oxycodone self-administration while preserving its analgesic efficacy in a rat model of neuropathic painAdriaan W Bruijnzeel, Azin Behnood-Rod, Ranjithkumar Chellian, et al.Pediatric Cardiology|May 5, 2023
Improvement in Palivizumab Administration Prior to Discharge for Hospitalized Infants with Hemodynamically Significant Congenital Heart Disease: A Quality Improvement InitiativeAndrea L Jones, Matthew J Campbell, Brittany Abernathy, et al.The Journal of Cell Biology|March 8, 2019
MACF1 links Rapsyn to microtubule- and actin-binding proteins to maintain neuromuscular synapsesJulien Oury, Yun Liu, Ana Töpf, et al.Journal of Cell Science|December 12, 2001
Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH bindingG Zhou, W J Mo, P Sebbel, et al.Drugs & Aging|April 9, 2005
Cytochrome p450 polymorphisms in geriatric patients: impact on adverse drug reactions--a pilot studyTobias Egger, Harald Dormann, Gabi Ahne, et al.Pageof 217